Abstract
Radiation retinopathy is a common complication of radiation treatment, a standard treatment modality for selected uveal melanoma patients. Although radiation offers high levels of ocular control, radiation complications can preclude useful visual function. An unmet need exists for new approaches to the management of uveal melanoma treatment to avoid such complications. In this review, we explore several important trials underway which have the possibility to change the conventional management approach.